Vabomere
PHONETIC PRONUNCIATION: Vabomere
Description
Vabomere: A Comprehensive Guide on Uses, Dosage, Demographic, Side Effects, Interactions, and Generic Options Vabomere, a combination of two antibiotics, meropenem and vaborbactam, is used to treat complicated urinary tract infections (cUTIs), including pyelonephritis (kidney infection) caused by susceptible Enterobacteriaceae bacteria and Escherichia coli bacteria. In this article, we’ll discuss the uses, dosage, demographic, side effects, interactions, and generic options related to Vabomere. Uses: As mentioned, Vabomere is used to treat cUTIs caused by susceptible Enterobacteriaceae bacteria and E. coli bacteria. It works by preventing the bacteria’s cell walls from forming, thereby killing them. In addition, vaborbactam enhances the effectiveness of meropenem against certain beta-lactamase enzymes that bacteria may produce to resist antibiotics. Dosage: Vabomere should only be administered under the direct supervision of a healthcare provider. The typical dosage for adults with cUTIs is 4g every eight hours, infused intravenously over three hours. The duration of treatment varies and depends on the severity of the infection and the patient's response to treatment. Demographic: Vabomere is typically prescribed for adults, and its usage in children has not been established. Vabomere is not recommended for use during pregnancy, as it may harm the fetus. Whether it is safe during breastfeeding has not been established. Side Effects: As with any medication, there is a risk of side effects with Vabomere. The most common side effects reported include headache, diarrhea, nausea, and vomiting. More severe side effects include allergic reactions, seizures, and Clostridioides difficile-associated diarrhea. Patients with a history of seizures or who are taking certain medications with the potential to cause seizures should use Vabomere with caution. Interactions: Vabomere can interact with other medications, potentially leading to adverse effects. For example, it can reduce the effectiveness of certain types of birth control, such as hormonal contraceptives and intrauterine devices (IUDs). It can also interact with anticonvulsants, increasing the risk of seizures. Before beginning Vabomere treatment, be sure to discuss all other medications you are taking with your healthcare provider. Generic Options: Vabomere is a brand name drug and does not have a generic equivalent at this time. However, the two active ingredients, meropenem and vaborbactam, can be obtained separately and used together in a process called “component-based therapy.” This approach may be less expensive than Vabomere but requires additional time and resources for preparation. Conclusion: Vabomere is an effective medication for cUTIs caused by susceptible Enterobacteriaceae and E. coli bacteria. It is intended for use only under the supervision of a healthcare provider and has a range of potential side effects and drug interactions. Understanding the uses, dosage, demographic, side effects, interactions, and generic options related to Vabomere is important for ensuring safe and effective treatment of cUTIs.
Faq for Vabomere
Answer: Vabomere is an antibiotic combination medication used for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis, caused by designated susceptible bacteria in adult patients.
Answer: Vabomere contains two active ingredients, meropenem and vaborbactam. Meropenem is a carbapenem antibiotic that inhibits bacterial cell wall synthesis, while vaborbactam is a beta-lactamase inhibitor that helps prevent the breakdown of meropenem by certain resistant bacteria. This combination effectively treats cUTIs caused by susceptible bacteria.
Answer: Common side effects of Vabomere include headache, diarrhea, nausea, constipation, skin rash, and injection site reactions. It may also cause serious allergic reactions or severe diarrhea due to bacterial overgrowth. It is important to consult your healthcare provider for a comprehensive list of potential side effects.
Answer: Vabomere is given as an intravenous (IV) infusion over a period of approximately 3 hours. The dose and duration of treatment will depend on the severity of the infection and other individual factors. It is administered by a healthcare professional in a hospital or clinical setting.
Answer: It is important to inform your healthcare provider about any allergies, medical conditions, or medications you are currently taking before starting Vabomere. It may interact with certain medications, such as valproic acid, so caution is necessary. Use of Vabomere during pregnancy or breastfeeding should be discussed with a healthcare provider.
Answer: Vabomere is not approved for use in pediatric patients below the age of 18 years. Safety and effectiveness have not been established in this population.